HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis.

AbstractBACKGROUND:
This study was designed to determine whether overexpression of the enzyme dimethylarginine dimethylaminohydrolase (DDAH) could enhance angiogenesis by reducing levels of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA).
METHODS AND RESULTS:
In DDAH1 transgenic (TG) and wild-type mice (each n=42), the role of DDAH overexpression on angiogenesis was studied by use of the disk angiogenesis system and a murine model of hindlimb ischemia (each n=21). After surgery, animals were treated with either PBS or the NOS inhibitors ADMA or N(omega)-nitro-L-arginine methyl ester (L-NAME; each 250 micromol x kg(-1) x d(-1)) by use of osmotic minipumps (each n=7). L-NAME was chosen to study an inhibitor that is not degraded by DDAH. Neovascularization in the disk angiogenesis system was impaired by both NOS inhibitors; however, TG animals were resistant to the effects of ADMA on neovascularization. Similarly, TG mice were more resistant to the inhibitory effect of ADMA on angioadaptation (angiogenesis and arteriogenesis) after hindlimb ischemia, as assessed by fluorescent microsphere studies and postmortem microangiograms. Enhanced neovascularization and limb perfusion in TG mice were associated with reduced plasma and tissue ADMA levels and enhanced tissue NOS enzyme activity.
CONCLUSIONS:
We describe a novel mechanism by which DDAH regulates postnatal neovascularization. Therapeutic manipulation of DDAH expression or activity may represent a novel approach to restore tissue perfusion.
AuthorsJohannes Jacobi, Karsten Sydow, Georges von Degenfeld, Ying Zhang, Hayan Dayoub, Bingyin Wang, Andrew J Patterson, Masumi Kimoto, Helen M Blau, John P Cooke
JournalCirculation (Circulation) Vol. 111 Issue 11 Pg. 1431-8 (Mar 22 2005) ISSN: 1524-4539 [Electronic] United States
PMID15781754 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Nitrates
  • Nitrites
  • Recombinant Fusion Proteins
  • Nitric Oxide
  • N,N-dimethylarginine
  • Arginine
  • Nitric Oxide Synthase
  • Amidohydrolases
  • dimethylargininase
  • NG-Nitroarginine Methyl Ester
Topics
  • Amidohydrolases (genetics, physiology)
  • Animals
  • Arginine (analogs & derivatives, blood, pharmacokinetics, pharmacology)
  • Enzyme Induction
  • Female
  • Hindlimb (blood supply)
  • Humans
  • Ischemia (physiopathology)
  • Laser-Doppler Flowmetry
  • Mice
  • Mice, Transgenic
  • Microspheres
  • Muscle, Skeletal (blood supply)
  • NG-Nitroarginine Methyl Ester (pharmacology)
  • Neovascularization, Physiologic (physiology)
  • Nitrates (blood)
  • Nitric Oxide (physiology)
  • Nitric Oxide Synthase (antagonists & inhibitors)
  • Nitrites (blood)
  • Prostheses and Implants
  • Recombinant Fusion Proteins (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: